Balance Sheet

Accounts Payables Accumulated Expenses Assets Capital Leases Cash & Current Investments Cash & Equivalents Common Equity Current Assets Current Leases Current Taxes Goodwill Goodwill & Intangibles Intangibles Inventory Liabilities and Shareholders Equity Liabilities from Discontinued Operations Liabilities from Discontinued Operations Long-Term Deferred Tax Long-Term Investments Minority Interest Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deferred Tax Liability Notes Payables Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Prepaid Assets Property, Plant & Equipment (Net)Property, Plant & Equipment (Net)Receivables Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Short term Debt Short-term Investments Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Growth Metrics

Cresco Labs (CRLBF) Shares Outstanding (2023)

Cresco Labs filings provide 1 years of Shares Outstanding readings, the most recent being $19.0 million for Q4 2023.

On a quarterly basis, Shares Outstanding changed N/A to $19.0 million in Q4 2023 year-over-year; TTM through Dec 2023 was $19.0 million, a N/A change, with the full-year FY2023 number at $19.0 million, changed N/A from a year prior.
Shares Outstanding hit $19.0 million in Q4 2023 for Cresco Labs.
In the past five years, Shares Outstanding ranged from a high of $19.0 million in Q4 2023 to a low of $19.0 million in Q4 2023.